SWOG clinical trial number
SWOG-8721

A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer

69% Accrual
Accrual
69%
Closed
Phase
69% Accrual
Accrual
69%
Published
Abbreviated Title
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer
Activated
09/01/1987
Closed
09/01/1991

Research committees

Gastrointestinal Cancer

Other Clinical Trials

S2303
SWOG Clinical Trial Number

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS >/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)

Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
CTSU/A022101
SWOG Clinical Trial Number

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)

Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
Phase
S2107
SWOG Clinical Trial Number

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
100% Accrual
Accrual
100%
Open
Phase